Member Info for philg65

An upbeat interview with feet firmly on the ground and no over promising. So hopefully by end of Q4 , then some more tangible business developments including update on the integration with the big biopharma.

Just market manipulation by those pesky MMs.

It will take an RNS of significant commercial slant to finally push this over the edge and a rerate.

Dabbler,

Wressmy whatever should be renamed. Good point about the cash burn being used for R&D. The board with the likes of Unicorn Asset Management investment, know exactly what the long term prospects will be. Options set at just over 4p and I can see us bursting through that when the Biopharma agreement reaches commercialisation (fingers X).

Cash burn in line with expectations. Good RNS and excellent future potential and no nasty surprises. Traders can look elsewhere!

There might be a rally to start if the results are an improvement but the key factor will be future growth and expectations.

Just be patient with this little baby as it will take time. I think slot depends on the continuing progress of the current deal with the biopharma.

Like I've said before, I think it will be ...meeting the board expectations and no more. These disti deals will take time to generate some real revenue so business as usual. They may prove me wrong with higher uptake than expected.

I would love this to establish a level above 2p to 2.5p. Whatever happened to Mr Ramper, moneymunch!!??

Not exactly great volume so it could be just a single investor just wanting out

Looking at higher revenues as was intimated end of Q1, although I don't expect massive fireworks. General progress of the disti deals and also any progress on the big Biopharma deal.

Some people do like to broadcast...it's in their nature. As for I've been buying more post....I'm sure he's got a shed load. I still think that at anything under the eighties will be a good buy.

Don't remember him saying that he sold...more like that he was taking a break from the board and still holding.

It did and I was going to invest more. I still feel that we could be looking at 2p by year end.

Timmit,

That was my buy. Here's hoping that we can surpass 1p

Could knock this up to 2.5p

Wress...another really factual statement.

Interestingly, large number of buys coming through and not even a tick up.

Already bought a handful this morning but not showing.

Holding out for alot more than 3.5+ even by year end. Originally looking at 10p plus but may have to revise that slightly down to 5-7p, unless we get any major good surprises!

Read the RNS news feed as it highlights it there (3rd Sept).

The company did mention earlier in the year that their revenue stream for the first half is ahead of all of 2017, however I know that the Sterling weakness might have a more significant affect on current trading.

Albinio,

I suspect that they feel that there is another information through social media to keep the public interest. It is on their website, however issuing an RNS to state that everything is fine would be great but just can't see them adopting that path.

Let's see what the results day produces as I expect better revenue figures (although that shouldn't be too difficult) and an update with the big bio pharma etc.

Jeez...how much further can this go down!!!

Good write up on CLP today in the Evening Standard. Talks mainly about the Bitcoin part of the business and how Hardin wants to setup a Bitcoin Trading arm once the firm has mined enough of the Cryptocurrency.